Tech Company Financing Transactions
Neuronoff Funding Round
Neuronoff secured a $5 million financing round on 1/30/2025. Backers included National Institutes of Health and The US Department of Defense.
Transaction Overview
Company Name
Announced On
1/30/2025
Transaction Type
Debt
Amount
$5,000,000
Round
Undisclosed
Proceeds Purpose
The DOD funding will support a clinical randomized controlled trial in collaboration with the University of Texas Health Science Center in Houston, TX.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
11000 Cedar Ave. 290
Cleveland, OH 44106
USA
Cleveland, OH 44106
USA
Phone
Undisclosed
Website
Email Address
Overview
Neuronoff is at the forefront of neuromodulation technology, specializing in minimally invasive solutions for chronic conditions. The company's flagship product, the Injectrode®, is pioneering elegant neuromodulation therapies to offer Drug-Free and Non-Opioid alternatives for conditions ranging from chronic pain to autonomic, bladder, cardiac, and inflammatory disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Manfred Franke
Browse more venture capital transactions:
Prev: 1/30/2025: Paxton venture capital transaction
Next: 1/30/2025: Oxyle venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs